UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibiotics in the clinical pipeline in October 2019

Journal of antibiotics, 2020-06, Vol.73 (6), p.329-364

2020

Volltextzugriff (PDF)

The antibiotic resistance crisis, with a focus on the United States

Journal of antibiotics, 2017-05, Vol.70 (5), p.520-526

2017

Volltextzugriff (PDF)

Cabanillasin, a new antifungal metabolite, produced by entomopathogenic Xenorhabdus cabanillasii JM26

Journal of antibiotics, 2013-10, Vol.66 (10), p.617-620

2013

Volltextzugriff (PDF)

Endophytic actinomycetes: promising source of novel bioactive compounds

Journal of antibiotics, 2017-05, Vol.70 (5), p.514-519

2017

Volltextzugriff (PDF)

Novel narrow spectrum benzyl thiophene sulfonamide derivatives to control Campylobacter

Journal of antibiotics, 2019-07, Vol.72 (7), p.555-565

2019

Volltextzugriff (PDF)

The occurrence of antibiotic resistance genes in the microbiota of yak, beef and dairy cattle characterized by a metagenomic approach

Journal of antibiotics, 2021-08, Vol.74 (8), p.508-518

2021

Volltextzugriff (PDF)

Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery

Journal of antibiotics, 2014-01, Vol.67 (1), p.53-58

2014

Volltextzugriff (PDF)

Fosfomycin and nitrofurantoin: classic antibiotics and perspectives

Journal of antibiotics, 2021-09, Vol.74 (9), p.547-558

2021

Volltextzugriff (PDF)

Prospects for new antibiotics: a molecule-centered perspective

Journal of antibiotics, 2014-01, Vol.67 (1), p.7-22

2014

Volltextzugriff (PDF)

Towards a new science of secondary metabolism

Journal of antibiotics, 2013-07, Vol.66 (7), p.387-400

2013

Volltextzugriff (PDF)

Autophagy-regulating protease Atg4: structure, function, regulation and inhibition

Journal of antibiotics, 2017-09, Vol.71 (1), p.72-78

2017

Volltextzugriff (PDF)

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps

Journal of antibiotics, 2017-12, Vol.70 (12), p.1087-1096

2017

Volltextzugriff (PDF)

Glycopeptide antibiotics: back to the future

Journal of antibiotics, 2014-09, Vol.67 (9), p.631-644

2014

Volltextzugriff (PDF)

Sealutomicins, new enediyne antibiotics from the deep-sea actinomycete Nonomuraea sp. MM565M-173N2

Journal of antibiotics, 2021-05, Vol.74 (5), p.291-299

2021

Volltextzugriff (PDF)

An efficient method to screen for the soil bacteria producing therapeutically effective antibiotics

Journal of antibiotics, 2021-12, Vol.74 (12), p.850-855

2021

Volltextzugriff (PDF)

Antibiotics in the clinical pipeline at the end of 2015

Journal of antibiotics, 2017-01, Vol.70 (1), p.3-24

2017

Volltextzugriff (PDF)

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

Journal of antibiotics, 2020-09, Vol.73 (9), p.593-602

2020

Volltextzugriff (PDF)

Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection

Journal of antibiotics, 2023-05, Vol.76 (5), p.279-290

2023

Volltextzugriff (PDF)

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Journal of antibiotics, 2021-08, Vol.74 (8), p.519-527

2021

Volltextzugriff (PDF)

Antifungal peptides produced by actinomycetes and their biological activities against plant diseases

Journal of antibiotics, 2020-05, Vol.73 (5), p.265-282

2020

Volltextzugriff (PDF)

Rifaximin: beyond the traditional antibiotic activity

Journal of antibiotics, 2014-09, Vol.67 (9), p.667-670

2014

Volltextzugriff (PDF)

Comprehensive analysis of biosynthetic gene clusters in bacteria and discovery of Tumebacillus as a potential producer of natural products

Journal of antibiotics, 2023-06, Vol.76 (6), p.316-323

2023

Volltextzugriff (PDF)

YO-001A, a new antifungal agent produced by Streptomyces sp. YO15-A001

Journal of antibiotics, 2019-12, Vol.72 (12), p.986-990

2019

Volltextzugriff (PDF)

Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses

Journal of antibiotics, 2018-05, Vol.71 (5), p.485-494

2018

Volltextzugriff (PDF)

Recent progress in biodiversity research on the Xylariales and their secondary metabolism

Journal of antibiotics, 2021-01, Vol.74 (1), p.1-23

2021

Volltextzugriff (PDF)

1 – 25 von 6.670

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieFebs Letters

SpracheNorwegisch

KollektionNature Journals

Zeitschrift / SerieThe Journal Of Antibiotics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.670)
Mit Volltextzugriff
(6.577)

Publikationsform

Artikel
(6.670)

Sprache

Englisch
(6.670)
Japanisch
(3.859)
Russisch
(7)

Erscheinungsjahr

n.n

Thema

Microbiology
(6.589)
Biotechnology & Applied Microbiology
(6.198)
Immunology
(6.198)
Life Sciences & Biomedicine
(6.198)
Pharmacology & Pharmacy
(6.198)
Science & Technology
(6.198)
Drug Discovery
(3.318)
Pharmacology
(3.288)
Biological And Medical Sciences
(2.861)
Medical Sciences
(1.858)
Animals
(1.818)
Pharmacology. Drug Treatments
(1.799)
Anti-Bacterial Agents - Pharmacology
(1.646)
Fundamental And Applied Biological Sciences. Psychology
(1.464)
Magnetic Resonance Spectroscopy
(1.451)
Microbial Sensitivity Tests
(1.304)
Antibiotics
(1.253)
Fermentation
(1.172)
Humans
(1.114)
Molecular Structure
(1.086)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB*
(6.670)
MEDLINE
(6.225)

Zeitschrift / Serie

Journal Of Antibiotics
(6.670)
Journal Of Antibiotics = An International Journal Devoted To Research On Bioactive Microbial Products
(210)
J. Antibiot
(23)
J Antibiot
(1)
J. Antibiotics
(1)
J. Antibitot
(1)
The Journal Of Antibiotics = The Journal Of Antibiotics
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibiotics in the clinical pipeline in October 2019

The antibiotic resistance crisis, with a focus on the United States

Cabanillasin, a new antifungal metabolite, produced by entomopathogenic Xenorhabdus cabanillasii JM26

Endophytic actinomycetes: promising source of novel bioactive compounds

Novel narrow spectrum benzyl thiophene sulfonamide derivatives to control Campylobacter

The occurrence of antibiotic resistance genes in the microbiota of yak, beef and dairy cattle characterized by a metagenomic approach

Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery

Fosfomycin and nitrofurantoin: classic antibiotics and perspectives

Prospects for new antibiotics: a molecule-centered perspective

Towards a new science of secondary metabolism

Autophagy-regulating protease Atg4: structure, function, regulation and inhibition

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps

Glycopeptide antibiotics: back to the future

Sealutomicins, new enediyne antibiotics from the deep-sea actinomycete Nonomuraea sp. MM565M-173N2

An efficient method to screen for the soil bacteria producing therapeutically effective antibiotics

Antibiotics in the clinical pipeline at the end of 2015

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Antifungal peptides produced by actinomycetes and their biological activities against plant diseases

Rifaximin: beyond the traditional antibiotic activity

Comprehensive analysis of biosynthetic gene clusters in bacteria and discovery of Tumebacillus as a potential producer of natural products

YO-001A, a new antifungal agent produced by Streptomyces sp. YO15-A001

Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses

Recent progress in biodiversity research on the Xylariales and their secondary metabolism

Aktive Filter

Suchergebnisse filtern